Drug Shortage Report for JAMP-EZETIMIBE
Report ID | 192236 |
Drug Identification Number | 02423235 |
Brand name | JAMP-EZETIMIBE |
Common or Proper name | Ezetimibe Tablets, USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-05-10 |
Estimated end date | 2023-08-18 |
Actual end date | 2023-08-08 |
Shortage status | Resolved |
Updated date | 2023-08-09 |
Company comments | Disruption of the manufacture of the drug. Blister 3x10 available under allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-08-09 | English | Compare |
v4 | 2023-08-08 | French | Compare |
v3 | 2023-08-08 | English | Compare |
v2 | 2023-05-11 | French | Compare |
v1 | 2023-05-11 | English | Compare |
Showing 1 to 5 of 5